id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-4195	Chen, Yang-Yi; Chen, Chieh-Hsun ; Lan, Cheng-Che Eric 	Real-World Experience of Upadacitinib Dosing Reduction in Patients With Moderate Atopic Dermatitis: A Case Series Study in Taiwan	2024	3	.pdf	application/pdf	1439	90	60	This study aimed to evaluate the impact of tapering upadacitinib from 30 mg daily to 15 mg daily on disease control in AD patients. This obser- vation suggests that in AD patients with less severe skin lesions, EASI-90 response may be maintained after upadacitinib dosage is tapered.	cache/dpc-4195.pdf	txt/dpc-4195.txt